Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
3(38%)

Phase Distribution

Ph phase_4
2
25%
Ph not_applicable
5
63%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(3)
Terminated(3)
Other(2)

Detailed Status

Completed3
Terminated3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (28.6%)
N/A5 (71.4%)

Trials by Status

unknown225%
completed338%
terminated338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8